Skip to main content
Premium Trial:

Request an Annual Quote

Susan Siegel

Illumina has named Susan Siegel to its board of directors. Siegel is chief innovation officer at General Electric and CEO of GE Ventures, which invests in startups and commercializes GE's intellectual property. Prior to joining GE, she was a general partner at Mohr Davidow Ventures, where she led investments in personalized medicine, digital health, and life sciences. Siegel was a founding representative member of the National Institutes of Health's National Center for Advancing Translational Sciences and also served on the Precision Medicine Initiative Working Group of the Advisory Committee to the NIH Director.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.